Drug Discovery

Bacteria
#Aston University #Drug discovery #Funding #Microbiology #University of Warwick

UK university partnership wins £1.8m for drug discovery research

A team from Aston University and the University of Warwick has secured a £1.8 ($2.2) million grant to engineer microbial cell factories to produce membrane proteins which will support future drug screening and sustainable chemical production. The Engineering Biology Mission Award was given by UK Research… Read More

#News

Researchers in a lab
#Drug development #Gene therapy #iPSC #Preclinical development #Webinar

How iPSC derived cells can support drug and gene therapy development

DDW recently hosted a webinar ‘Discover how iPSC derived cells can be used to support the development of drug and gene therapies’, supported by DefiniGEN. The event outlined how iPSC derived cells can be used to advance the efficiency and efficacy of disease modelling and covered topics including… Read More

#Exclusive Content

business deal
#Acquisition #Biotech #Drug development #Investment #Mergers and acquisitions

Novo Holdings acquires Catalent for $16.5 billion 

Catalent and Novo Holdings, a holding and investment company that manages the assets and wealth of the Novo Nordisk Foundation, have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion.  Novo Holdings will acquire… Read More

#News

Antibodies attacking virus
#Biomarkers #Drug discovery #Omics #Podcast #Proteins #Proteomics

Advancing precision medicine: Sengenics i-Ome Discovery microarrays

Professor Jonathan Blackburn, Chief Scientific Officer (CSO) of Sengenics, featured in a sponsored DDW Sitting Down With podcast to discuss the advantages of functional protein microarrays, challenges to overcome for biomarker discovery, Sengenics’ new i-Ome Discovery chip, and more. Professor Blackburn began by sharing an overview… Read More

#Exclusive Content

Boston waterfront
#AI / data analytics / healthtech / informatics #Lab automation #Lab technology #SLAS2024

SLAS2024: Day Two Highlights

Scientific sessions Tuesday’s presentations spanned a range of topics, including functional genomics for target identification, next-generation proteomics, self-driving laboratories, the future of cell culture, and ‘lab on a particle’ technology. There were some great talks on the DDW-hosted Ignite Theater track, co-sponsored by Hamamatsu Corporation and… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Automation / robotics #Digitalisation #Lab technology

How digital innovation is helping therapeutics to get to market faster

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. From finding potential active substances and identifying novel targets, to simulating how drugs will function in the human body and… Read More

#Exclusive Content

Boston waterfront
#AI / data analytics / healthtech / informatics #Lab automation #Lab technology #SLAS2024

SLAS2024: Day One Highlights

Opening keynote Following a change to the schedule, Juliet Williams of Kymera Therapeutics launched the event with a popular keynote talk ‘Solving Big Problems with Small Molecule Degraders’. Williams discussed the advantages of the company’s ‘disease agnostic’ small molecule degraders, and its success so far in translating results… Read More

#News #Trending News

2024 predictions, road forward
#2024 predictions #AstraZeneca #BioSenic #Cancer #Drug discovery #Mosaic Therapeutics #Oncology #OrganaBio #Phesi #Therapeutics

2024 predictions: Experts weigh in on cancer research

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on what to expect from cancer research and immunotherapies. Greg Rossi, Senior Vice… Read More

#Cancer Research #Exclusive Content #Opinion #Trends & Analysis

Cell and gene therapy concept
#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

Cell and gene therapy market: Hear from the experts

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.   Join this… Read More

#News

Boston, MA
#AI / data analytics / healthtech / informatics #Events #Lab technology #SLAS2024

Join the DDW team at SLAS2024 in Boston

The DDW team is looking forward to meeting you at SLAS2024, Boston, US on 3-7 February. New for this year is the DDW track at the SLAS Ignite Theater, co-sponsored by Integra Biosciences and Hamamatsu Corporation. Industry experts will share their experiences of… Read More

#News

Cell and gene therapy concept
#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

Register now: Cell and gene therapy opportunities webinar

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.   Join this… Read More

#News

Digital technology concept
#AI / data analytics / healthtech / informatics #Events #Lab technology #SLAS2024

The journey from lab to patient

By Megan Thomas, DDW Multimedia Editor The last time the DDW team were in Boston for a SLAS event two years ago, the world was very much in the early recovery period of Covid-19. For many, it was their first in-person event – a welcome return. In… Read More

#Exclusive Content

Miami skyline
#Advanced Therapies #Cell and gene therapy #Drug development #Manufacturing #Viral vectors

What challenges does the advanced therapies sector face? 

Over the three days of Advanced Therapies Week (ATW) 2024 in Miami, Florida, US, 16-19 January 2024, DDW’s Megan Thomas heard from attendees about the obstacles the sector needs to overcome to succeed.   Viral vector manufacturing   At the Advanced Therapies Awards ceremony, Dr Luigi Naldini,… Read More

#Exclusive Content #Opinion #Regulatory

384-well microplate
#Aurora Microplates #Drug development #Drug discovery #Lab technology

High-performance microplates for discovery sciences

This paid-for advertorial by Aurora Microplates appeared in DDW Volume 25 – Issue 1, Winter 2023/2024 Aurora Microplates is 100% focused on making the highest quality, highest performing microplates available. Aurora uses the best materials, the cleanest and most precise moulding operations and facilities to deliver high-performance microplates in… Read More

#Exclusive Content

Conference microphone
#AI / data analytics / healthtech / informatics #Biotherapeutics #Events #Lab technology #SLAS2024

SLAS2024 speaker update: Is pharma’s commercial model dying?

DDW is delighted to announce the final speaker on its SLAS2024 Ignite Theater track ‘Innovation & technology: from lab to patient’, co-sponsored by Integra Biosciences and Hamamatsu Corporation. Dipanwita Das On Monday 5 February at 11.30am, Dipanwita Das, CEO and Co-founder of Sorcero,… Read More

#News